PREVEntion and regReSsive effect of weight-loss and risk factor modification on Atrial Fibrillation: The REVERSE-AF study

Europace

Volumn 20, Issue 12, 2018, Pages 1929-1935

  Middeldorp, Melissa E ^a   Pathak, Rajeev K ^a   Meredith, Megan ^a   Mehta, Abhinav B ^b   Elliott, Adrian D ^a   Mahajan, Rajiv ^a   Twomey, Darragh ^a   Gallagher, Celine ^a   Hendriks, Jeroen M L ^a   Linz, Dominik ^a   McEvoy, R Doug ^c   Abhayaratna, Walter P ^d   Kalman, Jonathan M ^e   Lau, Dennis H ^a   Sanders, Prashanthan ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Atrial fibrillation; Obesity; Progression; Reversal; Risk factor management

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; BODY WEIGHT LOSS; COHORT ANALYSIS; DISEASE BURDEN; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART ATRIOVENTRICULAR NODE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; COMPLICATION; HEART PACING; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

ABLATION TECHNIQUES; AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; CARDIAC PACING, ARTIFICIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGRESSION-FREE SURVIVAL; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WEIGHT LOSS;

EID: 85055732456     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euy117     Document Type: Article

References (20)

1. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2008;11:423–34.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92: 1954–68.
3. Tsang TS, Barnes ME, Miyasaka Y, Cha SS, Bailey KR, Verzosa GC et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J 2008;29:2227–33.
4. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm 2012;9:473–80.
5. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: a Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol 2015;65:2159–69.
6. Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. Eur Heart J 2016;37:1573–81.
7. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace 2018;20: 157–208.
8. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the “second factor”. J Am Coll Cardiol 2009;53:1182–91.
9. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010;55:725–31.
10. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011;91:265–325.
11. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol 2014;63:2335–45.
12. Fynn SP, Todd DM, Hobbs WJ, Armstrong KL, Fitzpatrick AP, Garratt CJ. Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:135–41.
13. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100:87–95.
14. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 2010;55:2319–27.
15. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009;119:2146–52.
16. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565–71.
17. Abed HS, Samuel CS, Lau DH, Kelly DJ, Royce SG, Alasady M et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013;10:90–100.
18. Mahajan R, Lau DH, Brooks AG, Shipp NJ, Manavis J, Wood JP et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol 2015;66:1–11.
19. Dimitri H, Ng M, Brooks AG, Kuklik P, Stiles MK, Lau DH et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm 2012; 9:321–7.
20. De Vos CB, Breithardt G, Camm AJ, Dorian P, Kowey PR, Le Heuzey JY et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am Heart J 2012;163:887–93.